HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.

AbstractOBJECTIVE:
The purpose of this work was to analyze outcome with focus on growth in infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies and identify maternal factors other than the autoantibodies increasing the risk of fetal heart block.
PATIENTS AND METHODS:
Thirty-two pregnancies in 30 anti-Ro52-positive mothers were included. Seven fetuses developed second-degree or third-degree atrioventricular block, 8 developed first-degree atrioventricular block, and 17 had normal atrioventricular conduction, as diagnosed by using Doppler echocardiography. Three of 6 surviving fetuses with second-degree or third-degree atrioventricular block received treatment with fluorinated steroids. Two fetuses with second-degree atrioventricular block converted to first-degree atrioventricular block without any signs of progression during the study period. Maternal and longitudinal infant data were collected from planned neonatal follow-up and childhood health records from birth to 12 months of age in 31 survivors.
RESULTS:
Women giving birth to infants with prenatal second-degree or third-degree atrioventricular block were older and with higher parity than those with first-degree atrioventricular block or normal atrioventricular conduction. Second-degree or third-degree atrioventricular block pregnancies were <40 completed weeks, whereas pregnancies with first-degree atrioventricular block or normal atrioventricular conduction had a normal duration. Fetuses with second-degree or third-degree atrioventricular block were retarded by -0.98 +/- 0.77 SD in weight at birth and did not show any catch-up during infancy. In contrast, fetuses with first-degree atrioventricular block or normal atrioventricular conduction had a weight reduction of -0.51 +/- 1.01 SD with a catch-up during the first months after birth.
CONCLUSIONS:
This report documents that newborns with autoantibody-mediated second-degree or third-degree atrioventricular block are retarded in growth, with no catch-up during infancy, whereas fetuses with first-degree atrioventricular block or normal atrioventricular conduction have a normal growth soon after birth. Increased maternal age and/or parity seem to carry an increased risk for fetal heart block.
AuthorsAmanda Skog, Marie Wahren-Herlenius, Birgitta Sundström, Katarina Bremme, Sven-Erik Sonesson
JournalPediatrics (Pediatrics) Vol. 121 Issue 4 Pg. e803-9 (Apr 2008) ISSN: 1098-4275 [Electronic] United States
PMID18381509 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Antinuclear
  • Autoantibodies
  • Ribonucleoproteins
  • SS-A antibodies
  • SS-A antigen
Topics
  • Antibodies, Antinuclear (blood, immunology)
  • Autoantibodies (blood, immunology)
  • Cohort Studies
  • Female
  • Fetal Development (physiology)
  • Fetal Diseases (epidemiology, immunology)
  • Follow-Up Studies
  • Gestational Age
  • Heart Block (epidemiology, immunology)
  • Humans
  • Infant, Newborn
  • Male
  • Maternal Age
  • Parity
  • Placental Circulation (immunology)
  • Pregnancy
  • Pregnancy Complications (epidemiology, immunology)
  • Pregnancy Outcome
  • Ribonucleoproteins (immunology)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: